“…By increasing the dose of inoculation to induce more severe disease or by using more susceptible candidate strains, such as C3HeB/FeJ (Lanoix et al, 2015; Henao-Tamayo et al, 2015; Li et al, 2015), TNF-α or IFN-γ knockout mice (Ehlers et al, 2001; Manca et al, 2001; Turner and Orme, 2004; Green et al, 2013; Dorhoi et al, 2014; Francisco et al, 2015; Olleros et al, 2015), the onset of TB and evaluation process in mice could be accelerated above that of C57BL/6 or BALB/c. In addition, further applications of in vivo tracer techniques could facilitate detection of the abundance and distribution of the bacillus, as well as continuous monitoring of lesion progress in target organs; using these approaches could improve the accuracy of pre-clinical research, have higher detection sensitivity and safety, and optimize the use of laboratory animals (Sugawara et al, 2009; Kong and Cirillo, 2010; Kong et al, 2010, 2016; Zhang et al, 2010; Ozeki et al, 2015; Kato et al, 2016). …”